FSD Pharma Inc. (HUGE)

NASDAQ: HUGE · IEX Real-Time Price · USD

0.480

-0.009 (-1.84%)

Apr 23, 2024, 10:37 AM EDT - Market open

FSD Pharma Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-17.9	-23.61	-35.29	-31.8	-39.13	-22.71	-3.52
Depreciation & Amortization	2.51	4.53	4.05	3.9	1.94	0.18	0
Share-Based Compensation	3.84	1.53	7.44	8.05	12.08	6.44	2.99
Other Operating Activities	0.73	-10.79	3.05	0.72	11.39	-2.4	0.38
Operating Cash Flow	-10.83	-28.33	-20.75	-19.13	-13.71	-18.49	-0.15
Capital Expenditures	0	-0.36	-0.5	0	-0.29	-4.03	-7.65
Acquisitions	0.03	0	0.77	0	0	2.04	0
Change in Investments	-0.3	-0.24	0	6.48	0.46	-8	0
Other Investing Activities	-	12.73	-	0.04	-0.4	-	-
Investing Cash Flow	-0.27	12.12	0.27	6.51	-0.23	-9.99	-7.65
Share Issuance / Repurchase	-2.94	-1.93	38.34	25.16	4.05	48.64	13.79
Debt Issued / Paid	-0.19	-0.14	-0.13	-0.99	-0.04	0	-0.01
Other Financing Activities	-	-	-	-	-	-3.77	-1.26
Financing Cash Flow	-3.13	-2.07	38.21	24.17	4.01	44.88	12.51
Net Cash Flow	-14.22	-18.28	17.73	11.56	-9.93	16.39	4.71
Free Cash Flow	-10.83	-28.7	-21.25	-19.13	-14.01	-22.52	-7.8
Free Cash Flow Margin	-	-	-	-	-	-	-30078.80%
Free Cash Flow Per Share	-0.27	-0.74	-0.61	-1.59	-1.99	-3.81	-3.56

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).